V
The startup utilizes patented solution preservation technology to enhance organ vitality and increase the availability of transplantable organs without the use of donor blood. This approach directly addresses the critical shortage of viable organs for patients suffering from organ failure globally.
Updated 2 months ago
Funding
$5.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
TFFunding rounds are not available yet.
Founders
Product
Features
- The startup utilizes patented solution preservation technology to enhance organ vitality and increase the availability of transplantable organs without the use of donor blood. This approach directly addresses the critical shortage of viable organs for patients suffering from organ failure globally.